Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 5 |
2009 | 1 |
2010 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.
Oncogene. 2007 Oct 4;26(45):6469-87. doi: 10.1038/sj.onc.1210477. Epub 2007 Apr 30.
Oncogene. 2007.
PMID: 17471238
Free PMC article.
Review.
Targeting the function of the HER2 oncogene in human cancer therapeutics.
Moasser MM.
Moasser MM.
Oncogene. 2007 Oct 11;26(46):6577-92. doi: 10.1038/sj.onc.1210478. Epub 2007 May 7.
Oncogene. 2007.
PMID: 17486079
Free PMC article.
Review.
Item in Clipboard
The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics.
Amin DN, Campbell MR, Moasser MM.
Amin DN, et al.
Semin Cell Dev Biol. 2010 Dec;21(9):944-50. doi: 10.1016/j.semcdb.2010.08.007. Epub 2010 Sep 9.
Semin Cell Dev Biol. 2010.
PMID: 20816829
Free PMC article.
Review.
Item in Clipboard
The HER family and cancer: emerging molecular mechanisms and therapeutic targets.
Sergina NV, Moasser MM.
Sergina NV, et al.
Trends Mol Med. 2007 Dec;13(12):527-34. doi: 10.1016/j.molmed.2007.10.002. Epub 2007 Nov 5.
Trends Mol Med. 2007.
PMID: 17981505
Free PMC article.
Review.
Item in Clipboard
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.
Sergina NV, Rausch M, Wang D, Blair J, Hann B, Shokat KM, Moasser MM.
Sergina NV, et al.
Nature. 2007 Jan 25;445(7126):437-41. doi: 10.1038/nature05474. Epub 2007 Jan 7.
Nature. 2007.
PMID: 17206155
Free PMC article.
Item in Clipboard
A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies.
Chien AJ, Illi JA, Ko AH, Korn WM, Fong L, Chen LM, Kashani-Sabet M, Ryan CJ, Rosenberg JE, Dubey S, Small EJ, Jahan TM, Hylton NM, Yeh BM, Huang Y, Koch KM, Moasser MM.
Chien AJ, et al.
Clin Cancer Res. 2009 Sep 1;15(17):5569-75. doi: 10.1158/1078-0432.CCR-09-0522. Epub 2009 Aug 25.
Clin Cancer Res. 2009.
PMID: 19706807
Free PMC article.
Clinical Trial.
Item in Clipboard
Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.
Moasser MM, Wilmes LJ, Wong CH, Aliu S, Li KL, Wang D, Hom YK, Hann B, Hylton NM.
Moasser MM, et al.
J Magn Reson Imaging. 2007 Dec;26(6):1618-25. doi: 10.1002/jmri.21196.
J Magn Reson Imaging. 2007.
PMID: 17968965
Free PMC article.
Item in Clipboard
Cite
Cite